Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Levobupivacaine
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Study Phase : Phase IV
Recipient : Kuopio University Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable
Efficacy of Rectal Sheath Analgesia After Midline Laparotomy
Details : Levobupivacaine is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of General Surgery.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
August 17, 2016
Lead Product(s) : Levobupivacaine
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Highest Development Status : Phase IV
Recipient : Kuopio University Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Oxycodone Hydrochloride
Therapeutic Area : Neurology
Study Phase : Phase IV
Recipient : Kuopio University Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable
The Safety and Efficacy of Epidural Oxycodone
Details : Oxycodone is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Pain, Postoperative.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
October 12, 2015
Lead Product(s) : Oxycodone Hydrochloride
Therapeutic Area : Neurology
Highest Development Status : Phase IV
Recipient : Kuopio University Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Oxycodone Hydrochloride
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Phase IV
Recipient : Kuopio University Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable
The Effect of Oxycodone to the Placental Circulation at Early Labour
Details : Oxycodone is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Labor Pain.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
October 12, 2015
Lead Product(s) : Oxycodone Hydrochloride
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Phase IV
Recipient : Kuopio University Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Fentanyl
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Phase IV
Recipient : Kuopio University Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable
Intranasal Fentanyl in Treatment of Labour Pain
Details : Fentanyl is a Controlled Substance drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Labor Pain.
Product Name : Undisclosed
Product Type : Controlled Substance
Upfront Cash : Inapplicable
October 08, 2015
Lead Product(s) : Fentanyl
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Phase IV
Recipient : Kuopio University Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Oxycodone Hydrochloride
Therapeutic Area : Gastroenterology
Study Phase : Phase IV
Recipient : Kuopio University Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable
Opioid Induced Bowel Dysfunction in Patients Undergoing Cesarean Section
Details : Oxycodone is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Constipation.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
October 08, 2015
Lead Product(s) : Oxycodone Hydrochloride
Therapeutic Area : Gastroenterology
Highest Development Status : Phase IV
Recipient : Kuopio University Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
